These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7690504)

  • 21. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
    Tisdale M; Schulze T; Larder BA; Moelling K
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits.
    Stahlhut M; Li Y; Condra JH; Fu J; Gotlib L; Graham DJ; Olsen DB
    Protein Expr Purif; 1994 Dec; 5(6):614-21. PubMed ID: 7532052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
    Goedken ER; Marqusee S
    Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
    Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
    Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.
    Chattopadhyay D; Evans DB; Deibel MR; Vosters AF; Eckenrode FM; Einspahr HM; Hui JO; Tomasselli AG; Zurcher-Neely HA; Heinrikson RL
    J Biol Chem; 1992 Jul; 267(20):14227-32. PubMed ID: 1378437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
    Gao HQ; Boyer PL; Arnold E; Hughes SH
    J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
    FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
    Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
    Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT) RNase H by small RNA hairpins and dumbbells.
    Hannoush RN; Carriero S; Min KL; Damha MJ
    Chembiochem; 2004 Apr; 5(4):527-33. PubMed ID: 15185377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts.
    Zhang WH; Svarovskaia ES; Barr R; Pathak VK
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10090-5. PubMed ID: 12119402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of C-terminal structural elements of equine infectious anemia virus reverse transcriptase in DNA polymerase and ribonuclease H activities.
    Rausch JW; Arts EJ; Wöhrl BM; Le Grice SF
    J Mol Biol; 1996 Apr; 257(3):500-11. PubMed ID: 8648620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer.
    Ding J; Jacobo-Molina A; Tantillo C; Lu X; Nanni RG; Arnold E
    J Mol Recognit; 1994 Jun; 7(2):157-61. PubMed ID: 7530020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis of Gln294 of the reverse transcriptase of human immunodeficiency virus type-2 and its effects on the ribonuclease H activity.
    Bochner R; Duvshani A; Adir N; Hizi A
    FEBS Lett; 2008 Aug; 582(18):2799-805. PubMed ID: 18625228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 RT enhances the activity of a tethered dimer of HIV-1 proteinase.
    Goobar-Larsson L; Larsson PT; Debouck C; Towler EM
    Biochem Biophys Res Commun; 1996 Mar; 220(1):203-7. PubMed ID: 8602845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
    Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
    Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit.
    Jonckheere H; Taymans JM; Balzarini J; Velázquez S; Camarasa MJ; Desmyter J; De Clercq E; Anné J
    J Biol Chem; 1994 Oct; 269(41):25255-8. PubMed ID: 7523383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
    Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
    FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p66 Trp24 and Phe61 are essential for accurate association of HIV-1 reverse transcriptase with primer/template.
    Agopian A; Depollier J; Lionne C; Divita G
    J Mol Biol; 2007 Oct; 373(1):127-40. PubMed ID: 17804012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H.
    Schulze T; Nawrath M; Moelling K
    Arch Virol; 1991; 118(3-4):179-88. PubMed ID: 1712581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.